title: Restriction fragment length polymorphism analysis of HLA haplotypes in families with type I diabetes mellitus.
abstract: HLA Class II polymorphisms were analysed in 27 families with at least one Type I diabetic proband using Southern blotting technique according to 10th Histocompatibility Workshop Standards. The probes used were DRB, DQA1, DQB1 and DOB. We have studied 108 haplotypes and performed segregation analysis with HLA serology and restriction fragment length polymorphism (RFLP) data and compared "affected" with "non-affected" haplotypes (not inherited by IDDM patients). RFLPs correlated well with DR and DQ serology and detected additional polymorphisms. In particular, DQB polymorphism analysis showed segregation of the DQw3 splits with 88.5% of the DR4 affected haplotypes bearing the DQw3.2 split (now DQw8) and 11.5% the DQw3.1 split (now DQw7) while in the non-affected DR4 haplotypes 33.3% were DQw3.2 and 66.6% were DQw3.1. Haplotype analysis showed that DR4-DQw3.2 was in strong linkage with the U fragment (2.1 kb Taq I) of DQA2 (DX alpha) and with the L fragment (5.4 kb BamH I) of DOB. This study confirms previous observations of DQB polymorphisms in heterozygous IDDM patients, supports the protective effect of DQw3.1 (DQw7) against the development of the disease and demonstrates the importance of DQw3.2 (DQw8) for susceptibility to Type I diabetes.
authors.affiliation: Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, London, England.
authors.forename: K
authors.initials: K
authors.lastname: Badenhoop
authors.forename: G
authors.initials: G
authors.lastname: Schwarz
authors.forename: P
authors.initials: P
authors.lastname: Bingley
authors.forename: V
authors.initials: V
authors.lastname: Lewis
authors.forename: V
authors.initials: V
authors.lastname: Drummond
authors.forename: E A
authors.initials: EA
authors.lastname: Gale
authors.forename: G F
authors.initials: GF
authors.lastname: Bottazzo
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000235:genetics* / Q000276:immunology; D006680:HLA Antigens / Q000235:genetics*; D006681:HLA-D Antigens / Q000235:genetics; D006683:HLA-DQ Antigens / Q000235:genetics; D006684:HLA-DR Antigens / Q000235:genetics; D006239:Haplotypes; D000949:Histocompatibility Antigens Class II; D006650:Histocompatibility Testing; D006801:Humans; D010375:Pedigree; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length
chemical_list: C416186:H-2O antigen; D006680:HLA Antigens; D006681:HLA-D Antigens; C046148:HLA-DO antigens; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II